
Thank you ESMO - Eur. Oncology #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma #ESMOAmbassadors Asociación Peritoneum Appendix Cancer PMP Research Foundation Hospital Universitario 12 de Octubre


The best way to close out ESMO - Eur. Oncology meeting after lectures is sharing time with colleagues MD Anderson Cancer Center. I may be working at Vanderbilt University Medical Center now but we are friends forever! 🙏🏻 Arvind Dasari, MD, MS Drs. M Overman and Alda Tam. #ESMOGI25 #ESMOAmbassadors #cancer #CancerResearch


Bye bye Barcelona, very busy but very fruitful ESMO - Eur. Oncology #ESMOGI25 Full of science, networking and colleagues that are becoming a second family #ESMOGI26 📍Munich 🗓️1-4 July 2026 #ESMOAmbassadors


Results from EORTC EORTC-1607 / ABC-09 presented at ESMO - Eur. Oncology #ESMOGI25 Advanced BTC First-line CisGem+Pembro Phase II - Biomarker discovery 📸 Full details ⬆️CPS - longer PFS ⬆️CD8/Treg - responders ⬇️PD-L1+CD4, PD-L1+CD8 on treatment (regardless of response) #ESMOAmbassadors


My selection of posters for #PDAC from ESMO - Eur. Oncology #ESMOGI25 👉Understanding the impact of some of the molecular alterations identified in outcome - important to put into context some of the emerging data: KRAS, CDKN2A, Claudine 👉Novel IO strategies coming #ESMOAmbassadors


My selection of posters for #BTC from ESMO - Eur. Oncology #ESMOGI25 👉TOURMALINE - efficacy data in 📸1 👀Impact of steroids… 📸3 #ESMOAmbassadors


My selection of posters for #NET and #rareGItumours from ESMO - Eur. Oncology #ESMOGI25 #ESMOAmbassadors


The relevance of a WIDE molecular profiling in #PDAC and #BiliaryMalignancies Our data from Fundación Jiménez Díaz presented at ESMO - Eur. Oncology #ESMOGI25 👉Targets in PDAC are identified when wide pannels are used-regardless of KRAS 🧬MTAP loss present both in PDAC and BTC #ESMOAmbassadors


My selection of the highlights in hepato-pancreato-biliary from ESMO - Eur. Oncology #ESMOGI25 summarised by Teresa Macarulla 🤖PANOVA3 - QoL with TTFields in PDAC 🫷TALENTACE - Intermediate stage HCC 🎯Inpagratinib - FGF19 +ve HCC 🧬Olaparib in HRD BTC #ESMOAmbassadors


Teresa Macarulla nicely summarizes new data on #HPB cancers presented at #ESMOGI2025 #HCC #BTC #CCA #PDAC #ESMOAmbassadors ESMO - Eur. Oncology Post n.2


Teresa Macarulla nicely summarizes new data on #HPB cancers presented at #ESMOGI2025 #HCC #BTC #CCA #PDAC #ESMOAmbassadors ESMO - Eur. Oncology


My selection of posters for #HCC from ESMO - Eur. Oncology #ESMOGI25 👀Biomarkers for AtezoBev 🌍Lots of RWD presented 🤝MDT is paramount #ESMOAmbassadors


Closing remarks at ESMO - Eur. Oncology #ESMOGI25 Take home messages by #MichelDucreux on #ESMOGuidelines 🧐Large portfolio 🏃🏻♀️Living guidelines 🗣️Slide decs available 🌏PAGA: towards global guidelines 😊Feedback always welcome Full info: esmo.org/guidelines #ESMOAmbassadors


Closing remarks at ESMO - Eur. Oncology #ESMOGI25 Patient perspective lecture by #Dice Many steps to improve 👉Early diagnosis- let’s be proactive 👀Early on-set 🤝Decision making beyond signing informed consent 🫂Communication - what, how, when matters #ESMOAmbassadors


Patient’s perspective presented by #ZoranaMaravic Digestive Cancers Europe at #ESMOGI2025 #ESMOAmbassadors tejal kale.


Closing remarks at ESMO - Eur. Oncology #ESMOGI25 “Biomarker-driven therapy has transformed oncology” Keynote lecture by #JosephTabernero #ESMOAmbassadors


Promising results of olaparib as a potential new #PrecisionOncology treatment for patients with biliary tract cancer #BTC #CCA and aberrant #HRR mutations. #ESMOGI25 #ESMOAmbassadors ESMO - Eur. Oncology

dailyreporter.esmo.org/esmo-gastroint… ESMO - Eur. Oncology #ESMOGI2025 #ESMOAmbassadors

Josep Tabernero lecture on lessons learned from #GI translational research and the path forward at #ESMOGI25 ESMO - Eur. Oncology #ESMOAmbassadors


Josep Tabernero nicely give us a Lecture about lessons learn from GI translational research and the path forward. Thank you Josep for sharing it with us #ESMOGI25 #ESMOAmbassadors ESMO - Eur. Oncology Vall d’Hebron Institute of Oncology (VHIO)
